Drug Type Virus-like particle vaccine, Prophylactic vaccine  | 
Synonyms Receptor Binding Domain (RBD) COVID19 Vaccine Serum Institute of India/SpyBiotech, Viruslike particle (VLP) vaccine Serum Institute of India/SpyBiotech  | 
Target  | 
Action inhibitors  | 
Mechanism SARS-CoV-2 S protein inhibitors(SARS-CoV-2 S protein inhibitors)  | 
Therapeutic Areas  | 
Active Indication-  | 
Inactive Indication  | 
Originator Organization  | 
Active Organization-  | 
Inactive Organization  | 
License Organization-  | 
Drug Highest PhasePendingPhase 1/2  | 
First Approval Date-  | 
Regulation-  | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| COVID-19 | Phase 2 | Australia   | 31 Jul 2020 | 





